Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Progressive leukoencephalopathy impairs neurobehavioral development in sialin-deficient mice.

Stroobants S, Van Acker NG, Verheijen FW, Goris I, Daneels GF, Schot R, Verbeek E, Knaapen MW, De Bondt A, Göhlmann HW, Crauwels ML, Mancini GM, Andries LJ, Moechars DW, D'Hooge R.

Exp Neurol. 2017 May;291:106-119. doi: 10.1016/j.expneurol.2017.02.009. Epub 2017 Feb 9.

2.

Haploinsufficiency of VGluT1 but not VGluT2 impairs extinction of spatial preference and response suppression.

Callaerts-Vegh Z, Moechars D, Van Acker N, Daneels G, Goris I, Leo S, Naert A, Meert T, Balschun D, D'Hooge R.

Behav Brain Res. 2013 May 15;245:13-21. doi: 10.1016/j.bbr.2013.01.042. Epub 2013 Feb 5.

PMID:
23396167
3.

JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity.

Arts J, King P, Mariën A, Floren W, Beliën A, Janssen L, Pilatte I, Roux B, Decrane L, Gilissen R, Hickson I, Vreys V, Cox E, Bol K, Talloen W, Goris I, Andries L, Du Jardin M, Janicot M, Page M, van Emelen K, Angibaud P.

Clin Cancer Res. 2009 Nov 15;15(22):6841-51. doi: 10.1158/1078-0432.CCR-09-0547. Epub 2009 Oct 27.

4.

IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity.

Cryns K, Shamir A, Van Acker N, Levi I, Daneels G, Goris I, Bouwknecht JA, Andries L, Kass S, Agam G, Belmaker H, Bersudsky Y, Steckler T, Moechars D.

Neuropsychopharmacology. 2008 Feb;33(3):674-84. Epub 2007 Apr 25.

5.

Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.

Mamidi RN, Mannens G, Annaert P, Hendrickx J, Goris I, Bockx M, Janssen CG, Kao M, Kelley MF, Meuldermans W.

Drug Metab Dispos. 2007 Apr;35(4):566-75. Epub 2007 Jan 12.

PMID:
17220243
6.

Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain.

Moechars D, Weston MC, Leo S, Callaerts-Vegh Z, Goris I, Daneels G, Buist A, Cik M, van der Spek P, Kass S, Meert T, D'Hooge R, Rosenmund C, Hampson RM.

J Neurosci. 2006 Nov 15;26(46):12055-66.

7.

Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse.

Moechars D, Depoortere I, Moreaux B, de Smet B, Goris I, Hoskens L, Daneels G, Kass S, Ver Donck L, Peeters T, Coulie B.

Gastroenterology. 2006 Oct;131(4):1131-41.

PMID:
17030183
8.

Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.

Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I, Daneels G, Bouwknecht JA, Steckler T.

J Neurosci. 2006 Aug 30;26(35):9022-9.

9.

The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans.

Mannens GS, Hendrickx J, Janssen CG, Chien S, Van Hoof B, Verhaeghe T, Kao M, Kelley MF, Goris I, Bockx M, Verreet B, Bialer M, Meuldermans W.

Drug Metab Dispos. 2007 Apr;35(4):554-65. Epub 2006 Aug 25.

PMID:
16936066
10.

Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice.

Cryns K, Shamir A, Shapiro J, Daneels G, Goris I, Van Craenendonck H, Straetemans R, Belmaker RH, Agam G, Moechars D, Steckler T.

Neuropsychopharmacology. 2007 Apr;32(4):881-91. Epub 2006 Jul 12.

11.

Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53.

Peeters PJ, Baker A, Goris I, Daneels G, Verhasselt P, Luyten WH, Geysen JJ, Kass SU, Moechars DW.

Brain Res Dev Brain Res. 2004 Jun 21;150(2):89-101.

PMID:
15158073
12.
13.

Effect of the serotonin agonist 8-OH-DPAT on the sensorimotor system of the rat.

Demeulemeester H, Feys H, Goris I, Zwaenepoel I, de Weerdt W, de Sutter P, Gybels J, Plets C, Nuttin B.

Pharmacol Biochem Behav. 2001 Sep;70(1):95-103.

PMID:
11566146

Supplemental Content

Support Center